Division of Transplant Surgery
The Division of Organ Transplantation is an exciting and growing division with leading surgeons, clinicians, and professionals working together to improve patient care. It is at the forefront of critical advances in transplation and continues to be an active participant in national trials evaluating the efficacy of various drug regimens in improving outcomes, reducing rejection rates, and enhancing quality of life.
|Paul Morrissey, MD
|Kevin Charpentier, MD||Reza Saidi, MD|
The Division of Organ Transplantation has recently instituted protocols for reducing alloantibody levels in highly sensitized patients using intravenous immunoglobulins (IVIG) Velcade, plasmapheresis, and anti-CD20 antibody (Rituximab). Currently, the division is involved in several on-going research projects and employs three full-time research associates.
|PI: P. Morrissey
Kidney Donor Outcomes Cohort (KDOC) Study
Period: 3/2011 - 2/2015
|PI: Charpentier||Comparison of Perioperative Outcomes After Liver Resection for Benign and Malignant Liver Lesions
Thrombocytosis as a predictor for post-operative complication in pancreatic surgery patients
Microbiomes in Diseases of the Pancreas
Ascites after Irreversible Electroporation
|PI: Morrissey||A single institution experience and outcomes of using bovine carotid artery graft for permanent hemodialysis vascular access
Kidney Donor Outcomes Cohort (KDOC) study